S&P 500 EQUAL WEIGHTED Consumer Discretionary...
S2530/05/2024 23:04:31 | Chg. +61.28 | Ouverture | Haut | Bas | Précédent Fermer |
---|---|---|---|---|---|
5,039.34XXP | +1.23% | 4,978.06 | 5,050.10 | 4,978.06 | 4,978.06 |
GlobeNewswire
07:05
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GlobeNewswire
07:05
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
GlobeNewswire
07:00
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type ...
GlobeNewswire
07:00
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with typ...
GlobeNewswire
07:00
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
GlobeNewswire
06:08
Sen. John Cornyn delivers remarks at Driscoll Children's Hospital Rio Grande Valley
GlobeNewswire
05:00
Flash News: OKX to List Ultiverse's Token on its Spot Market, Expanding Trading Options
GlobeNewswire
04:38
Avaada Energy Secures 1050 MWp Solar Project in NTPC Auction; Crosses over 15 GWp Portfolio in India
GlobeNewswire
03:41
United States Government to Reinstate Section 301 Import Tariffs on Artificial Graphite from China
GlobeNewswire
03:16
Lowey Dannenberg, P.C. is Investigating Akero Therapeutics, Inc. (“Akero”) (NASDAQ: AKRO) for Potent...
GlobeNewswire
03:00
ENPHASE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Agai...
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Spr...
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Int...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page